Filters
cris logo
-
New search Filters
Select from list
Displayed from Show more
You have reached the maximum number of displayed search results.
All results displayed
No results are available for the search performed
Displayed from
You have reached the maximum number of displayed search results.
All results displayed
Loading results
Obtaining statistical data

Igor Virant

Igor Virant
no.: 35763 source: ARIS

researcher – active in research organisation
ivirantat signonko-i.si
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Evaluation (rules)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
15.2
A''
0
A'
12.92
A1/2
12.92
CI10
5
CImax
3
h10
2
A1
0.06
A3
0
Data for the last 5 years (citations for the last 10 years) on April 27, 2024; A3 for period 2018-2022 (update for tender in 2023: NO)
Data for ARIS tenders ( 12.01.2024 – Project tender, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 3  4  3  1 
Scopus 2  6  5  2.5 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  B. Sc.     SI University of Ljubljana, Faculty of Pharmacy 2004 
Specialization  Clinical Pharmacy Specialist    SI 2010 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position ecris.org.employ_rolegroup Title
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research  11/15/2004    Researcher  Teaching Assistant 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. J7-4635  MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy   2022 - 2024  PhD Lucija Peterlin Mašič  6,052 
2. J3-2529  Role of endothelium in tumor response to radiotherapy   2020 - 2023  PhD Boštjan Markelc  3,338 
3. J1-8140  Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for environmental hazard in zdravje ljudi   2017 - 2020  PhD Metka Filipič  3,739 
Confirmation required
Views history
Favourite